Mounjaro Dosing Guide: The Step-Up Schedule Explained
We talk a lot about how much weight Mounjaro can help people lose. We talk considerably less about how you are supposed to get there.
Tirzepatide doesn’t go from zero to 15 mg overnight. The dose is introduced gradually and increased over time, giving the body an opportunity to adjust.
The short version
• Mounjaro is a once-weekly injection that acts on two gut hormone pathways, GIP and GLP-1.
• The dose starts at 2.5 mg and goes up in steps of 2.5 mg, no sooner than every 4 weeks.
• Not everyone needs 15 mg. The best dose is the lowest one that works for you and that you tolerate.
• It should be started and adjusted by a doctor who knows your health history.
What exactly is Mounjaro?
Tirzepatide, sold as Mounjaro, has changed the conversation around type 2 diabetes and obesity. But a medicine that can produce 15 to 20 per cent or more weight loss is not a nutritional supplement.
It is often called a “GLP-1 injection”, but strictly it works on two hormone pathways, so doctors call it a dual GIP/GLP-1 receptor agonist. Together, the two pathways help the body release insulin when blood sugar is high, reduce glucagon (a hormone that raises blood sugar), slow how fast the stomach empties so you feel full for longer, and reduce appetite. The result can be much better blood sugar control and, in suitable people, significant weight loss.
Who is it approved for in India?
CDSCO has approved tirzepatide for two uses. It is not meant for anyone who would simply like to lose a few kilograms.
|
Use |
Who it is for |
|
Type 2 diabetes |
Adults whose type 2 diabetes is not well controlled, together with diet and exercise. |
|
Chronic weight management |
Adults with a BMI above 30 kg/m², or a BMI above 27 and below 30 kg/m² with at least one weight-related condition. Used together with a reduced-calorie diet and more physical activity. |
|
Weight-related conditions include |
High blood pressure, abnormal cholesterol or fats (dyslipidaemia), obstructive sleep apnoea, heart or blood vessel disease, prediabetes, type 2 diabetes. |
How much weight can Mounjaro help you lose?
The answer should come from clinical trials, not social media photographs. In the SURMOUNT-1 trial (New England Journal of Medicine), 2,539 adults with obesity, or overweight with a weight-related complication, but without diabetes, received tirzepatide 5, 10 or 15 mg weekly, or placebo, for 72 weeks. Doses were raised gradually over 20 weeks.
|
Dose |
Average weight reduction at 72 weeks |
|
5 mg |
15.0% |
|
10 mg |
19.5% |
|
15 mg |
20.9% |
|
Placebo |
3.1% |
On 15 mg, 57% of people lost at least 20% of their body weight and about 36% lost at least 25%. These are group averages, not promises. For someone weighing 100 kg, a 20% loss would be about 20 kg, and individual results can be much higher or lower.
Who should prescribe it, and what is checked first?
Do not start it on a friend’s prescription or an online “weight-loss package”. The Government of India says GLP-1 medicines should be used under specialist supervision: endocrinologists and internal medicine specialists, and cardiologists for certain indications.
Before you start, your doctor should review your BMI and metabolic risk, any diabetes and current medicines, stomach, gallbladder and pancreas history, whether you could become pregnant, and any condition that rules the medicine out.
The step-up schedule
Move up a step only after at least four weeks on the current dose, and only if your doctor agrees. The slow pace gives your body time to adjust to common stomach effects such as nausea, diarrhoea and vomiting.
|
Step |
Weekly dose |
Notes |
|
Step 1 (start) |
2.5 mg |
Starter dose. Lets your body adjust and improves stomach tolerance. |
|
Step 2 |
5 mg |
First usual working dose. For some people a perfectly good long-term dose. |
|
Step 3 |
7.5 mg |
Only if more benefit is needed and the current dose is well tolerated. |
|
Step 4 |
10 mg |
Same rule: increase only if needed and tolerated. |
|
Step 5 |
12.5 mg |
Same rule: increase only if needed and tolerated. |
|
Step 6 (maximum) |
15 mg |
The highest recommended adult dose. A ceiling, not a target. |
Every step is at least 4 weeks, and every dose is injected once a week.
Dose escalation is individual
Two people taking tirzepatide for the same reason can sensibly be on different doses. One may do well at 5 mg, another may need more, and another may need a slower approach. The right dose is the one that gives enough benefit with acceptable comfort and safety, not the highest one you can tolerate.
Please do not speed up the schedule. “More medicine means more weight loss” is not a good strategy. Faster increases mainly mean more nausea, vomiting and diarrhoea.
Your weekly injection, step by step
Your doctor or nurse will show you how to use your pen. The routine is simple: one injection, once a week.
1. Take the pen out. Pens are kept in the fridge (2–8 °C) and never frozen. A pen already in use can stay out of the fridge, up to 30 °C, for up to 21 days.
2. Pick your day. Use the same day each week, at any time of day, with or without food.
3. Choose a spot. Stomach (abdomen) or thigh. The back of the upper arm works too, but someone else needs to give that injection. Use a different spot each week.
4. Inject under the skin. Follow the leaflet that comes with your pen. Do not use it if the liquid looks cloudy or has particles.
5. Missed a dose? Take it within 4 days (96 hours). After that, skip it and take the next dose on your usual day.
If you also use insulin, inject the two separately, not mixed together, and not right next to each other.
What should you know about safety?
Thyroid tumours
Mounjaro carries a boxed warning in the US prescribing information because it caused thyroid C-cell tumours in animals. Whether this happens in people is not known, and thyroid cancer in humans has not been proven. It must not be used if you, or anyone in your family, has had medullary thyroid carcinoma (MTC), or if you have MEN 2 (Multiple Endocrine Neoplasia type 2). Tell your doctor about a neck lump, hoarseness that does not go away, or trouble swallowing or breathing.
Your eyes (if you have diabetes)
Blood sugar that improves very quickly can temporarily worsen diabetic retinopathy. People who already have it should be monitored. New vision changes (blurred vision, floaters, missing patches or loss of vision) should never be put down to “just a side effect”, so get an eye check.
Before surgery or sedation
Tirzepatide slows stomach emptying. Tell your anaesthetist or surgical team before any procedure needing general anaesthesia or deep sedation, because food or liquid left in the stomach can pass into the lungs.
Stomach and body: what is common, and what needs a call
Tirzepatide is not recommended if you have severe gastroparesis (a stomach that empties very slowly).
|
How serious |
What you might notice |
What to do |
|
Common |
Nausea, diarrhoea, vomiting, constipation, stomach discomfort, indigestion. Often worst when starting or after a dose increase. |
Eat smaller meals, drink fluids, and tell your doctor if it keeps going. Your doctor may slow the schedule. |
|
Call your doctor soon |
Vomiting or diarrhoea that lasts, so you cannot keep fluids down, or you pass little urine (dehydration can harm the kidneys). Shakiness, sweating or confusion if you also take insulin or a sulfonylurea (low blood sugar). New vision changes. |
Contact your doctor the same day. |
|
Urgent |
Severe, lasting stomach pain, with or without vomiting (possible pancreatitis). Pain in the upper right belly, fever or yellow skin or eyes (possible gallbladder problem). Swelling of the face, lips or throat, or difficulty breathing (serious allergic reaction). |
Get medical help straight away. |
Do’s and don’ts
Do
• Start under the guidance of a qualified doctor.
• Stay on each dose for at least 4 weeks before any increase.
• Drink enough fluids, especially when you have stomach symptoms.
• Tell every doctor, dentist and anaesthetist that you use Mounjaro.
• Keep follow-up appointments and any eye checks you are advised.
• Combine it with a reduced-calorie diet and regular activity.
Don’t
• Use someone else’s prescription or an online “package”.
• Raise the dose early because you want faster results.
• Assume you must reach 15 mg.
• Use it if you or your family have had medullary thyroid carcinoma, or you have MEN 2.
• Ignore a severe or lasting stomach pain.
• Treat new vision problems as “just a side effect”.
The take-home message
Start low. Stay on each dose for at least four weeks. Increase only when appropriate. And do not assume that everyone needs 15 mg.
Mounjaro works best as a long-term metabolic treatment with the right patient selection and follow-up, not as a “weight-loss injection”. The goal is better health and lower metabolic risk, reached safely, not just a smaller number on the scale.
References
1. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. doi:10.1056/NEJMoa2206038.
2. Central Drugs Standard Control Organisation (CDSCO), Government of India. Approval of tirzepatide (Mounjaro), 20 March 2025, for type 2 diabetes mellitus and chronic weight management.
3. U.S. Food and Drug Administration. Mounjaro (tirzepatide) Prescribing Information. Safety information including the boxed warning, diabetic retinopathy complications, severe gastrointestinal adverse reactions, gallbladder disease and peri-procedural considerations.
4. Government of India, Press Information Bureau (Ministry of Health and Family Welfare). Regulatory surveillance over weight loss drug (GLP-1) supply chain, 24 March 2026.
For educational purposes only. This article is not a prescription or a substitute for individual medical advice. Tirzepatide should be started and adjusted under appropriate medical supervision. If you think you are having a medical emergency, get help immediately.
